It is proposed to continue research on the conformational and dynamic properties of plasminogen (92,000 Mr), with emphasis in understanding the structrure, function and biochemical regulation of the plasminogen heavy chain, in particular of its five kringles. Plasminogen kringles are 10,000 Mr strutural and folding domains constrained by three Cys-Cys bridges; they are responsible for anchoring plasminogen to fibrin and to blood clots, and probably mediate interactions with alpha 2-antiplasmin and with the plasminogen pre-activation peptide (haemostasis control factors). These interactions are thought to involve a lysine-binding site (LBS), known to be carried to kringle 1 (K1), K2 and, in all likelihood, by K5. K1, K4, K5 and the combined K2+3 are isolated by proteolytic cleavage of plasminogen extracted from human blood plasma. The kringles are then subjected to 1-D and 2-D NMR spectroscopy at 300 and 600 MHz (1H frequencies) both in 1H2O and in 2H2O. Particular emphasis will be placed on systematically characterizing the structural/steric requirements of ligand drugs and of short model synthetic polypeptide chains containing C-terminal L-Lys. From Overhauser studies and other chemical evidence on K4, it is proposed that the LBS is structured by the Cys51 -Cys75 loop, and involves polar residues Asp57 and Arg71, and the aromatic side chains of Phe 64 and Trp 72. The project involves extensive NMR experimentation aimed at identifying and assigning the complete kringles' spectra and at characterizing the conformational dynamics including H-exchange and ligand on-off binding kinetics. Since kringles are present in other blood plasma proteins such as prothrombin, the tissue plasminogen activator, fibronectin and haptoglobin, and in urokinase, a kidney plasminogen activator, it is clear that the proposed studies have implications in the understanding of key kringle-mediated protein-protein interactions in haemostasis. In this context, current efforts to develop emergency thrombosis therapy via bio-engineered plasminogen activators ought to be greatly assisted if the cloned kringles carried structural components which enhance their binding affinity to the fibrin clot. Furthermore, the proposed studies have direct bearing in the design of antifibrinolytic drugs aimed at promoting healing in the treatment of haemorragic disorders.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL029409-04
Application #
3340523
Study Section
Biophysics and Biophysical Chemistry B Study Section (BBCB)
Project Start
1982-07-01
Project End
1990-06-30
Budget Start
1985-07-01
Budget End
1986-06-30
Support Year
4
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Carnegie-Mellon University
Department
Type
Schools of Arts and Sciences
DUNS #
052184116
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Christen, Martin T; Frank, Pascal; Schaller, Johann et al. (2010) Human plasminogen kringle 3: solution structure, functional insights, phylogenetic landscape. Biochemistry 49:7131-50
Kim, Hyun Jin; Choi, Moo Young; Kim, Hyung J et al. (2010) Conformational dynamics and ligand binding in the multi-domain protein PDC109. PLoS One 5:e9180
Ozhogina, Olga A; Bominaar, Emile L (2009) Characterization of the kringle fold and identification of a ubiquitous new class of disulfide rotamers. J Struct Biol 168:223-33
Battistel, Marcos D; Grishaev, Alexander; An, Seong Soo A et al. (2009) Solution structure and functional characterization of human plasminogen kringle 5. Biochemistry 48:10208-19
Ozhogina, Olga A; Grishaev, Alexander; Bominaar, Emile L et al. (2008) NMR solution structure of the neurotrypsin Kringle domain. Biochemistry 47:12290-8
Grishaev, Alexander; Llinas, Miguel (2005) Protein structure elucidation from minimal NMR data: the CLOUDS approach. Methods Enzymol 394:261-95
Gehrmann, Marion L; Douglas, Justin T; Banyai, Laszlo et al. (2004) Modular autonomy, ligand specificity, and functional cooperativity of the three in-tandem fibronectin type II repeats from human matrix metalloproteinase 2. J Biol Chem 279:46921-9
Grishaev, Alexander; Llinas, Miguel (2004) BACUS: A Bayesian protocol for the identification of protein NOESY spectra via unassigned spin systems. J Biomol NMR 28:1-10
Frank, Pascal S; Douglas, Justin T; Locher, Michael et al. (2003) Structural/functional characterization of the alpha 2-plasmin inhibitor C-terminal peptide. Biochemistry 42:1078-85
Trexler, Maria; Briknarova, Klara; Gehrmann, Marion et al. (2003) Peptide ligands for the fibronectin type II modules of matrix metalloproteinase 2 (MMP-2). J Biol Chem 278:12241-6

Showing the most recent 10 out of 63 publications